Rich Quelch, global head of marketing at Origin discusses the role pre-filled syringes will play in delivering personalised drugs.
Pre-filled syringe
The future of medicine is personalised, based on treating individuals for their risk factors and replacing the traditional universal medicine approach.
A leading tool in the delivery of personalised medicine is pre-filled syringes, with over 10.2 million units expected to be sold worldwide by 2026. Pre-filled syringes are revolutionising the way medicine is controlled, delivered and adhered by providing benefits in safety, minimised waste and ease-of-use.